Evidence map›Paper›PMID 29643181›Full record

ArticleThe Journal of biological chemistry2018

Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts.

Wenduo Gu, Xuechong Hong, Alexandra Le Bras, Witold N Nowak, Shirin Issa Bhaloo, Jiacheng Deng, Yao Xie, Yanhua Hu, Xiong Z Ruan, Qingbo Xu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Fibroblast Heterogeneity in Inflammatory Bowel Disease.International journal of molecular sciences · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Wenduo GuSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Xuechong HongSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Alexandra Le BrasSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Witold N NowakSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Shirin Issa BhalooSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Jiacheng DengSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Yao XieSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Yanhua HuSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom.
Xiong Z RuanCentre for Lipid Research, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Department of Infectious Diseases, the Second Affiliated Hospital, Chongqing Medical University, Centre for Nephrology, University College London, Rowland Hill Street, London NW3 2PF, United Kingdom. Electronic address: x.ruan@ucl.ac.uk.
Qingbo XuSchool of Cardiovascular Medicine & Science, King's College London, British Heart Foundation Centre, London SE5 9NU, United Kingdom. Electronic address: qingbo.xu@kcl.ac.uk.
King's College London · GBRoland Hill (United Kingdom) · GB

Funding

British Heart Foundation RG/14/6/31144
6 · The paper itself

Abstract

Tissue-engineered vascular grafts with long-term patency are greatly needed in the clinical settings, and smooth muscle cells (SMCs) are a critical graft component. Human mesenchymal stem cells (MSCs) are used for generating SMCs, and understanding the underlying regulatory mechanisms of the MSC-to-SMC differentiation process could improve SMC generation in the clinic. Here, we found that in response to stimulation of transforming growth factor-β1 (TGFβ1), human umbilical cord-derived MSCs abundantly express the SMC markers α-smooth muscle actin (αSMA), smooth muscle protein 22 (SM22), calponin, and smooth muscle myosin heavy chain (SMMHC) at both gene and protein levels. Functionally, MSC-derived SMCs displayed contracting capacity

Indexed as

Blood Vessel ProsthesisCell DifferentiationMesenchymal Stem Cell TransplantationAnimalsCells, CulturedHumansHuman Umbilical Vein Endothelial CellsMesenchymal Stem CellsMiceMice, SCIDMicroRNAsMuscle, Smooth, VascularNeovascularization, PhysiologicSignal TransductionTransforming Growth Factor betaMicroRNAsTransforming Growth Factor betacell differentiationmesenchymal stem cells (MSCs)microRNA mechanismtissue engineeringtransforming growth factor beta (TGF-β)umbilical cord mesenchymal stem cellsvascular smooth muscle cells

Identifiers

PMID29643181
PMCPMC5971462
OpenAlexW2797704395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.